| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 44.753 | 23.356 | 51.498 | 58.199 | 56.134 | 58.138 | 54.995 | 59.516 |
| Total Income - EUR | - | - | 44.753 | 23.356 | 51.742 | 58.651 | 56.141 | 58.138 | 54.996 | 59.516 |
| Total Expenses - EUR | - | - | 37.858 | 20.846 | 43.581 | 55.943 | 54.835 | 55.407 | 48.618 | 63.815 |
| Gross Profit/Loss - EUR | - | - | 6.895 | 2.511 | 8.161 | 2.707 | 1.306 | 2.731 | 6.378 | -4.299 |
| Net Profit/Loss - EUR | - | - | 5.552 | 2.199 | 7.644 | 2.176 | 795 | 2.179 | 5.894 | -4.894 |
| Employees | - | - | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Med Vet Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.006 | 851 | 557 | 2.422 | 1.864 | 1.570 | 1.297 | 1.023 |
| Current Assets | - | - | 6.780 | 11.150 | 24.958 | 26.730 | 31.624 | 36.719 | 39.592 | 40.005 |
| Inventories | - | - | 5.130 | 8.508 | 18.239 | 23.966 | 21.553 | 26.590 | 33.941 | 33.229 |
| Receivables | - | - | 7 | 0 | 5.914 | 91 | 1.047 | 983 | 80 | 180 |
| Cash | - | - | 1.643 | 2.642 | 806 | 2.674 | 9.024 | 9.146 | 5.571 | 6.596 |
| Shareholders Funds | - | - | 5.640 | 7.735 | 15.229 | 17.116 | 17.531 | 19.765 | 25.599 | 20.562 |
| Social Capital | - | - | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | 2.246 | 4.297 | 10.279 | 12.030 | 15.982 | 18.524 | 15.290 | 20.466 |
| Income in Advance | - | - | 0 | 7 | 7 | 7 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4621 - 4621" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Med Vet Pharm Srl